Swiss National Bank
BCAB icon

Swiss National Bank’s BioAtla BCAB Stock Holding History

Swiss National Bank’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,004
Closed -$251K – 2748
2022
Q1 		$251K Buy
1,004
+152
+18% +$63.6K ﹤0.01% 2668
2021
Q4 		$836K Hold
852
– – ﹤0.01% 2538
2021
Q3 		$1.25M Buy
852
+492
+137% +$959K ﹤0.01% 2328
2021
Q2 		$763K Buy
+360
New +$813K ﹤0.01% 2557

Other funds holding BCAB

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Swiss National Bank's BCAB Position: Q2 2022 in Review

Swiss National Bank sold out of BioAtla (BCAB) in Q2 2022, closing a stake of 1,004 shares — an estimated $251K sold.

Swiss National Bank first reported a position in BCAB in Q2 2021 and held it in 4 quarters. The position peaked at $1.25M in Q3 2021. 76 funds tracked by Wall St. Rank hold BCAB as of Q2 2022.

  • Swiss National Bank reported no remaining BioAtla position as of Q2 2022 after selling out during the quarter.
  • Swiss National Bank sold 1,004 BioAtla shares in Q2 2022, an estimated $251K.
  • Swiss National Bank first reported a position in BioAtla in Q2 2021 and held it in 4 quarters.
  • Swiss National Bank's BioAtla position peaked at $1.25M in Q3 2021.
  • 76 funds tracked by Wall St. Rank held BioAtla as of Q2 2022.

Based on Swiss National Bank's 13F filing for Q2 2022, filed 9 Aug 2022.